ArticleHealth economics review2025
Cost-utility analysis of eptinezumab for migraine prevention in Taiwan.
Cheng-Shen Chan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleHealth economics review2025
Cheng-Shen Chan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.